Skip to content

Microlin Bio, Inc

company.status.inactive

CIK 1547530fmd_1HT4YQ0FQE5JQAVFXN75RC0FW5Finance, Insurance and Real Estate · Real EstateTemplate: Real estate

Coverage: Jan 01, 2012 to Sep 30, 2015, 13 periods

Latest annual · FY2015

Millions
Total revenues
0
Net income
(0)

Latest quarter · Q3 FY2015

Millions
Total revenues
0
Net income
(0)
Open Financials

Microlin Bio, Inc financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Revenue$8,47510-K 2015-04-15 · proof
Net income-$223,631-$107,85110-K 2015-04-15 · proof
Cash from operating activities-$37,526-$60,20210-K 2015-04-15 · proof
Total assets$97$379-74.4%10-Q 2015-11-16 · proof
Total liabilities$111,660$148,470-24.8%10-K 2016-05-27 · proof
Cash and cash equivalents$97$379-74.4%10-Q 2015-11-16 · proof
What was Microlin Bio, Inc's revenue in fiscal 2015?
Microlin Bio, Inc reported revenue of $8,475 for fiscal 2015 (the year ended Dec 31, 2014). Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was Microlin Bio, Inc's net income in fiscal 2015?
Microlin Bio, Inc reported net income of -$223,631 for fiscal 2015 (the year ended Dec 31, 2014), against -$107,851 the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What was Microlin Bio, Inc's cash from operating activities in fiscal 2015?
Microlin Bio, Inc reported cash from operating activities of -$37,526 for fiscal 2015 (the year ended Dec 31, 2014), against -$60,202 the year before. Source: the 10-K filed with the SEC on Apr 15, 2015. SEC
What are Microlin Bio, Inc's total assets?
As of Sep 30, 2015, Microlin Bio, Inc reported total assets of $97, against $379 a year earlier (-74.4%). Source: the 10-Q filed with the SEC on Nov 16, 2015. SEC
What are Microlin Bio, Inc's total liabilities?
As of Sep 30, 2015, Microlin Bio, Inc reported total liabilities of $111,660, against $148,470 a year earlier (-24.8%). Source: the 10-K filed with the SEC on May 27, 2016 (restated). SEC
What are Microlin Bio, Inc's cash and cash equivalents?
As of Sep 30, 2015, Microlin Bio, Inc reported cash and cash equivalents of $97, against $379 a year earlier (-74.4%). Source: the 10-Q filed with the SEC on Nov 16, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1547530&period_type=annual&limit=5"

Information only, not investment advice.